SPOTLIGHT -
November 19th 2024
As skepticism surrounding AI fades, pharma industry execs are ready to embrace the technology.
November 15th 2024
Ann Beliën, PhD, founder and CEO of Rejuvenate Biomed, discusses how AI is being used to find new ways to treat age-related conditions.
November 14th 2024
Exploring those areas and functions where the application of generative artificial intelligence—through use cases borne out in practice—are demonstrating tangible value and driving life sciences innovation to new heights.
Pleio’s chief experience officer discusses why these platforms are being embraced by the industry.
November 13th 2024
Pharma looks to take advantage of expanded access programs across Asia-Pacific region.
Turing Announces Shkreli Resignation, Appoints Interim CEO
December 21, 2015.
The Center for Drug Evaluation's Long To-Do List for 2016
December 18, 2015.
Retrophin Issues Statement on Indictment of Martin Shkreli
High Prevalence, Not Sales, to Drive Pancreatic Treatment Market to $2.9 Billion by 2021
Isis Pharmaceuticals Changes Company Name
Last Call To Enter 4A’s 2016 Partner Award in Health & Wellness
December 14, 2015.
AstraZeneca Agrees to Buy 55 Percent of Acerta Pharma
December 17, 2015.
Top Pharma Companies’ R&D Returns Continue to Slide, Says Study
Turing's Martin Shkreli Arrested
Transatlantic Cancer Collaboration Seeks to Accelerate Early Detection
December 15, 2015.
Sanofi and Boehringer Ingelheim in Business-Swap Agreement
Valeant Announces New Fulfillment Agreements With Walgreens
Deals Crucial to Offsetting $2.5 Billion Cost of Developing a Novel Drug, says Report
Mergers, Pricing, and New Technologies: The Top Health Issues of 2016
Mexican Authorities Approve First Vaccine for Dengue
December 11, 2015.
UK Researchers Crowdfund a Phase II Cancer Trial
Returning Rasi Outlines 5-Year Vision for EMA
December 10, 2015.
USP Announces Winners of Global Fellowship Awards
Pharma Outsourcing Mergers and Acquisitions "Set for Record Year in 2015"
Acute Myeloid Leukemia Treatment Market Set for Rapid Expansion
December 09, 2015.
California: “Ground Zero” for American Rx Price Controls
December 08, 2015.
Ovarian Cancer Treatment Market Boasts Strong Pipeline
Obama Signs Bill Extending Exclusivity of Drugs With Controlled Substances
December 07, 2015.
Final Rule on Labeling Changes Pushed Back to July 2016
J&J Completes Novira Therapeutics Acquisition
First Child-Friendly TB Medicines Available in Correct Doses
December 04, 2015.
Orphan Drug Market to Grow at Over 10% CAGR to 2019
Pharma Caught in Political Crosshairs
December 02, 2015.
Supply Chain Pains Turn to Gains
December 01, 2015.
Express Scripts Drive Access to $1 Alternative to Turing's Daraprim